Large-scale testing (Phase 3)UnknownNCT04867083What this trial is testingDual Therapy in HIV Patients in 4 Days a Week Versus 7 Days a WeekWho this might be right forHIV Infections ANRS, Emerging Infectious Diseases 440
Not applicableApproved For MarketingNCT00354627What this trial is testingThe TMC125-C214 Study Provides Early Access to TMC125 for HIV-1 Infected Patients Who Have Failed Multiple Antiretroviral Regimens and Will Also Gather Information on the Long-term Safety and Tolerability of TMC125 Combined With Other Antiretroviral DrugsWho this might be right forHIV-1 Tibotec Pharmaceuticals, Ireland
Testing effectiveness (Phase 2)Study completedNCT00000870What this trial is testingA Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to HAART AloneWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 200
Testing effectiveness (Phase 2)UnknownNCT02390466What this trial is testingOpen-label, Phase I/IIa Study of VAC-3S in HIV-1 Patients Who Showed an Immune Response to VAC-3S During IVVAC-3S/P1Who this might be right forHIV InnaVirVax 15
Early research (Phase 1)Ended earlyNCT05494866What this trial is testingA Trial of Cobicistat and Gemcitabine and Nab-Paclitaxel in Patients with Advanced Stage or Metastatic Pancreatic Ductal AdenocarcinomaWho this might be right forCYP3A InhibitorAdvanced Stage or Metastatic Pancreatic Ductal AdenocarcinomaPancreatic Cancer+2 more German Cancer Research Center 6
Not applicableStudy completedNCT00608569What this trial is testingDetermining the Effects of Observed and Self-Administered Drug Regimens in HIV Infected AdultsWho this might be right forHIV Infections Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 529
Post-approval studies (Phase 4)Ended earlyNCT00312754What this trial is testingA Phase IV Study of BMS-232632 in HIV+ Patients With Metabolic SyndromeWho this might be right forHIV Infections Bristol-Myers Squibb 70
Post-approval studies (Phase 4)Study completedNCT05898841What this trial is testingStudy to Evaluate the Efficacy and Safety of a Rilpivarine-based Antiretroviral Tratment Regimen in HIV- Infected Patients With Liver Metabolic Disease Who Maintain Udetectable HIV Viral LoadWho this might be right forHIV InfectionsFatty Liver Disease Fundacion SEIMC-GESIDA 63
Not applicableEnrolling By InvitationNCT05492565What this trial is testingSeville Cohort of People at Substantial Risk for HIV Infection on Pre-exposure ProphylaxisWho this might be right forHIV Infection PrimaryHepatitis, Viral, HumanSexually Transmitted Infections, Excluding HIV and Hepatitis Hospitales Universitarios Virgen del Rocío 500
Not applicableStudy completedNCT00557570What this trial is testingEvaluation and Monitoring of Patients With HIV InfectionnWho this might be right forHIV National Institute of Allergy and Infectious Diseases (NIAID) 600
Early research (Phase 1)Study completedNCT00006066What this trial is testingInterleukin-2 Plus Anti-HIV Therapy in HIV-Infected Children With Weakened Immune SystemsWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 92
Large-scale testing (Phase 3)Study completedNCT00004581What this trial is testingCompare Two Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Previously Received Anti-HIV TreatmentWho this might be right forHIV Infections Abbott 300
Not applicableStudy completedNCT01038401What this trial is testingResidual Replication of HIV-1 in the Gut Associated Lymphoid Tissue (GALT) of Patients on Highly Active Antiretroviral Therapy (HAART): the ANRS EP 44 StudyWho this might be right forHIV Infection ANRS, Emerging Infectious Diseases 30
Not applicableStudy completedNCT03690895What this trial is testingLong-term Outcome of AIDS-related Primary Central Nervous System Lymphoma Treated With High Dose Methotrexate and Combined Antiretroviral TherapyWho this might be right forCentral Nervous System LymphomaAIDS Related Lymphoma Fondation Ophtalmologique Adolphe de Rothschild 51
Not applicableLooking for participantsNCT00404989What this trial is testingAntiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People.Who this might be right forHIV InfectionsHepatitis B Syneos Health 24,258
Testing effectiveness (Phase 2)WithdrawnNCT03304717What this trial is testingReverse Transcriptase Inhibitors in Aicardi Goutières SyndromeWho this might be right forAicardi Goutières Syndrome Children's Hospital of Philadelphia
Early research (Phase 1)Study completedNCT03510468What this trial is testingImpact of Weekly Administration of Rifapentine and Isoniazid on Steady State Pharmacokinetics of Tenofovir Alafenamide in Healthy Volunteers (YODA)Who this might be right forHealthy Volunteers National Institutes of Health Clinical Center (CC) 51
Testing effectiveness (Phase 2)Study completedNCT00642291What this trial is testingAn Open-Label Study of Emtricitabine in Combination With Other Antiretroviral Agents in HIV Infected Pediatric SubjectsWho this might be right forHIV Infections Gilead Sciences 16
Not applicableStudy completedNCT00002308What this trial is testingStavudine in HIV-Infected Patients Who Have Not Had Success With Other Anti-HIV DrugsWho this might be right forHIV Infections Bristol-Myers Squibb
Testing effectiveness (Phase 2)Study completedNCT00945282What this trial is testingSafety and Tolerability Study to Evaluate Lower Dose of GSK2248761 in Antiretroviral Treatment-Naive HIV-1 Infected Adults.Who this might be right forInfection, Human Immunodeficiency Virus ViiV Healthcare 8